[vc_row full_width=”stretch_row” css=”.vc_custom_1531049302498{background-color: #1b1b1b !important;}”][vc_column][vc_wp_custommenu title=”Hot topics” nav_menu=”13″][/vc_column][/vc_row]

The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / June 23, 2021 /Schall Law Firm, a national shareholder rights law firm, is reminding investors of a class action lawsuit against Ocugen, Inc. (‘Ocugen’ or ‘the Company’) (NASDAQ: OCGN) for violations of 10 (b) and 20 (a) of the Securities Exchange Act of 1934 and Rule 10b-5, published by the Securities and Exchange Commission.

Investors who acquired the Company’s securities between February 2, 2021 and June 10, 2021 inclusive (the “Class Period”) are advised to contact the Company before August 17, 2021.

If you are a shareholder who has suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall law firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335 to discuss your rights free of charge. You can also contact us on the firm’s website at www.schallfirm.com or by email at [email protected].

In this case, the class has not yet been certified and you will not be represented by a lawyer until certified. If you do nothing, you can remain an absent class member.

According to the lawsuit, the company provided false and misleading information to the market. The information Ocugen submitted to the FDA regarding the development of a COVID-19 vaccine did not contain enough data to support an Emergency Authorization (‘EUA’). The company has not filed an EEA with the FDA. Because of these facts, the company’s public statements were false and materially misleading throughout the course period. When the market learned the truth about Ocugen, investors suffered.

Join the case to make up for your losses.

The law firm Schall represents investors worldwide and specializes in securities class actions and shareholder disputes.

This press release may be viewed as a solicitation in some jurisdictions under applicable law and ethical rules.

The story goes on

The Schall law firm
Brian Schall, Esq.,
Office: 310-301-3335
[email protected]

SOURCE: The Schall law firm

View source version on accesswire.com:
https://www.accesswire.com/652894/SHAREHOLDER-ACTION-NOTICE-The-Schall-Law-Firm-Reminds-Investors-of-a-Class-Action-Lawsuit-Against-Ocugen-Inc-and-Encourages- Investors-with-losses-in-excess-500,000-contact-the-company

Comments are closed.